Brought to you by:
Can tailored thromboprophylaxis reduce amputation risk?
One in five endovascular procedures fails within six months and for decades vascular surgeons have answered that statistic with the same blunt toolkit: aspirin, clopidogrel, or whatever combination a given surgeon prefers. This year’s Frank J. Veith Distinguished Lecture at…
Mechanical thrombectomy demonstrates superior outcomes to anticoagulation in DVT patients, analysis of RCT and registry data shows
Mechanical thrombectomy using the ClotTriever device (Inari Medical) for iliofemoral deep vein thrombosis (DVT) was found to be “associated with significantly” lower Villalta scores and a lower incidence of post-thrombotic syndrome (PTS) out to 12 months compared with treatment using anticoagulation,…
ABCs for the treatment of lower-extremity acute DVTs
Ashish Gupta, MD, outlines his ABCs for confronting and treating patients with acute deep vein thrombosis (DVT) of the lower extremity, and how he developed his dictums. A is for “anticoagulation” for not more than six months of duration. Rationale:…
Dispatches from the vascular front: COVID-19 strikes New Jersey like ‘tidal wave’
Operating in the shadow of New York City, Clifford M. Sales, MD, has had his finger on the pulse of North America’s two worst-affected regions since the scourge of COVID-19 first started to take hold locally. New York’s pandemic plight…